The EGF receptor family: spearheading a merger of signaling and therapeutics
- PMID: 17314037
- DOI: 10.1016/j.ceb.2007.02.008
The EGF receptor family: spearheading a merger of signaling and therapeutics
Abstract
The ErbB receptor tyrosine kinases evolved as key regulatory entities enabling the extracellular milieu to communicate with the intracellular machinery to bring forth the appropriate biological response in an ever-changing environment. Since its discovery, many aspects of the ErbB family have been deciphered, with emphasis on aberration of signaling in human diseases. However, only now, with the availability of the atomic coordinates of these receptors, can we construct a comprehensive model of the mechanisms underlying ligand-induced receptor dimerization and subsequent tyrosine kinase activation. Furthermore, the recent introduction of new high-throughput screening methodologies, combined with the materialization of a systems biology perspective, reveals an overwhelming network complexity, enabling robust signaling and evolvability. This knowledge is likely to impact our view of diseases as system perturbations and resistance to ErbB-targeted therapeutics as manifestations of robustness.
Similar articles
-
Oncogenic growth factor receptors: implications for signal transduction therapy.Semin Cancer Biol. 2004 Aug;14(4):262-70. doi: 10.1016/j.semcancer.2004.04.005. Semin Cancer Biol. 2004. PMID: 15219619 Review.
-
System properties of ErbB receptor signaling for the understanding of cancer progression.Mol Biosyst. 2007 Feb;3(2):111-6. doi: 10.1039/b612800a. Epub 2006 Dec 18. Mol Biosyst. 2007. PMID: 17245490 Review.
-
Potential for molecularly targeted therapy against epidermal growth factor receptor ligands.Anticancer Res. 2009 Mar;29(3):823-30. Anticancer Res. 2009. PMID: 19414315 Review.
-
The ErbB signaling network is coordinately expressed and activated in the mouse prostate.Prostate. 2004 Jun 15;60(1):68-75. doi: 10.1002/pros.20042. Prostate. 2004. PMID: 15129431
-
Molecular mechanisms of signal transduction: epidermal growth factor receptor family, vascular endothelial growth factor family, Kit, platelet-derived growth factor receptor, Ras.J BUON. 2007 Sep;12 Suppl 1:S83-94. J BUON. 2007. PMID: 17935283 Review.
Cited by
-
Review of novel therapeutic targets for improving heart failure treatment based on experimental and clinical studies.Ther Clin Risk Manag. 2016 Jun 3;12:887-906. doi: 10.2147/TCRM.S106065. eCollection 2016. Ther Clin Risk Manag. 2016. PMID: 27350750 Free PMC article. Review.
-
The role of neuregulin/ErbB2/ErbB4 signaling in the heart with special focus on effects on cardiomyocyte proliferation.Am J Physiol Heart Circ Physiol. 2012 Jun 1;302(11):H2139-47. doi: 10.1152/ajpheart.00063.2012. Epub 2012 Mar 16. Am J Physiol Heart Circ Physiol. 2012. PMID: 22427524 Free PMC article. Review.
-
Kinetic analysis of cytokine-mediated receptor assembly using engineered FC heterodimers.Protein Sci. 2013 Aug;22(8):1100-8. doi: 10.1002/pro.2285. Epub 2013 Jun 6. Protein Sci. 2013. PMID: 23703950 Free PMC article.
-
NRG1-ErbB4 signaling promotes functional recovery in a murine model of traumatic brain injury via regulation of GABA release.Exp Brain Res. 2019 Dec;237(12):3351-3362. doi: 10.1007/s00221-019-05680-2. Epub 2019 Nov 13. Exp Brain Res. 2019. PMID: 31720762
-
The Development of Positron Emission Tomography Tracers for In Vivo Targeting the Kinase Domain of the Epidermal Growth Factor Receptor.Pharmaceuticals (Basel). 2022 Apr 5;15(4):450. doi: 10.3390/ph15040450. Pharmaceuticals (Basel). 2022. PMID: 35455447 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous